Loading chat...

PA HB1715

Bill

Status

Introduced

7/10/2025

Primary Sponsor

Ann Flood

Click for details

Origin

House of Representatives

2025-2026 Regular Session

AI Summary

  • Adds Duchenne muscular dystrophy to the list of diseases that must be screened for under Pennsylvania's Newborn Child Screening and Follow-up Program
  • Amends the Newborn Child Testing Act of 1965, which requires physicians, hospitals, and other institutions to administer genetic disease tests to infants
  • Screening program is designed to help health care providers identify conditions that could cause intellectual disability, physical disability, or death if left untreated
  • Requires approval from the Newborn Screening and Follow-up Technical Advisory Board for implementation
  • Takes effect 60 days after enactment

Legislative Description

Further providing for Newborn Child Screening and Follow-up Program.

Last Action

Laid on the table

11/18/2025

Committee Referrals

Health7/10/2025

Full Bill Text

No bill text available